Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis

J Microbiol Immunol Infect. 2022 Dec;55(6 Pt 1):1129-1130. doi: 10.1016/j.jmii.2022.08.002. Epub 2022 Aug 8.

Authors

Chi-Kuei Hsu¹, Chien-Ming Chao², Chih-Cheng Lai³

Affiliations

¹ Department of Internal Medicine, E-Da Hospital, Kaohsiung, Taiwan. Electronic address: ospreyhsu@gmail.com.
² Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Taiwan. Electronic address: ccm870958@yahoo.com.tw.
³ Division of Hospital Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan. Electronic address: dtmed141@gmail.com.

No abstract available

Keywords: COVID-19; Ciclesonide; Inhaled corticosteroid.

Publication types

Meta-Analysis
Letter

MeSH terms

Administration, Inhalation
Anti-Asthmatic Agents* / therapeutic use
Asthma* / drug therapy
COVID-19*
Humans
Outpatients
Pregnenediones* / therapeutic use

Substances

ciclesonide
Pregnenediones
Anti-Asthmatic Agents